Table 2.
VM | WM | MF | VF | AP | EF | CS | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
r | p | r | p | r | p | r | p | r | p | r | p | r | p | |
Age (years) | −0.233* | 0.061 | −0.310* | 0.012* | −0.236* | 0.058 | −0.007 | 0.956 | 0.134 | 0.288 | −0.123 | 0.330 | −0.163 | 0.196 |
CP equivalent (mg/day) | −0.120 | 0.341 | −0.079 | 0.531 | −0.233* | 0.062 | 0.078 | 0.538 | −0.331* | 0.007** | −0.316* | 0.010* | −0.207* | 0.098 |
BP equivalent (mg/day) | −0.270* | 0.029* | −0.151 | 0.229 | −0.403** | 0.001** | 0.046 | 0.715 | −0.262* | 0.035* | −0.231* | 0.064 | −0.255* | 0.041* |
GAF score | 0.203* | 0.105 | 0.159 | 0.206 | 0.132 | 0.295 | 0.029 | 0.821 | 0.080 | 0.525 | 0.090 | 0.474 | 0.152 | 0.228 |
ManS total score | −0.139 | 0.271 | −0.177 | 0.159 | −0.196 | 0.117 | −0.031 | 0.809 | −0.193 | 0.123 | −0.226* | 0.070 | −0.213* | 0.088 |
DIEPSS total score | 0.021 | 0.870 | −0.024 | 0.851 | −0.137 | 0.276 | 0.064 | 0.615 | −0.106 | 0.403 | −0.096 | 0.449 | −0.058 | 0.648 |
Estimated full scale IQ | −0.042 | 0.741 | 0.154 | 0.220 | −0.083 | 0.512 | 0.213* | 0.088 | 0.340* | 0.006** | 0.314* | 0.011* | 0.213* | 0.088 |
Years of education | 0.258* | 0.045* | 0.158 | 0.225 | 0.178 | 0.169 | 0.114 | 0.383 | 0.261* | 0.042* | 0.246* | 0.056 | 0.261* | 0.042* |
Serum BDNF (ng/ml) | −0.161 | 0.201 | −0.079 | 0.532 | −0.252* | 0.043* | −0.115 | 0.362 | −0.196 | 0.118 | −0.110 | 0.383 | −0.203* | 0.104 |
“r” indicates Pearson's product-moment correlation coefficient; *|r| > 0.2, **|r| > 0.4; “p” indicates the p-value; *p < 0.05, **p < 0.01. CP, chlorpromazine; BP, biperiden; GAF, Global Assessment of Functioning; ManS, Manchester Scale for chronic psychosis; DIEPSS, Drug-Induced Extrapyramidal Symptoms Scale; VM, verbal memory; WM, working memory; MF, motor function; VF, verbal fluency; AP, attention and processing speed; EF, executive function; CS, composite score.